Genetics of epilepsies

Expert Review of Neurotherapeutics

Volumn 7, Issue 6, 2007, Pages 727-734

  Andrade, Danielle M ^a   Minassian, Berge A ^b  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

Epilepsy; Gene; Generalized; Genetics; Ion channel; Monogenic; Partial onset; Polygenic; Transient epilepsy

Indexed keywords

4 AMINOBUTYRIC ACID A RECEPTOR; CALCIUM CHANNEL; CHLORIDE CHANNEL; CHOLINERGIC RECEPTOR; POTASSIUM CHANNEL; SODIUM CHANNEL; SYNAPSIN I;

AUTOSOMAL DOMINANT INHERITANCE; DISEASE CLASSIFICATION; ENVIRONMENTAL FACTOR; EPILEPSY; FEBRILE CONVULSION; FOCAL EPILEPSY; GENE INTERACTION; GENE MUTATION; GENERALIZED EPILEPSY; GENETIC IDENTIFICATION; GENETICS; GRAND MAL SEIZURE; HUMAN; INFANCY; INHERITANCE; MYOCLONUS EPILEPSY; PHENOTYPE; PROTEIN MOTIF; REVIEW; TEMPORAL LOBE EPILEPSY;

ANIMALS; BRAIN; EPILEPSY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MODELS, GENETIC; MODELS, NEUROLOGICAL; NERVE TISSUE PROTEINS;

EID: 34250377246     PISSN: 14737175     EISSN: 17448360     Source Type: Journal    
DOI: 10.1586/14737175.7.6.727     Document Type: Review

References (88)

1. Metrakos K, Metrakos JD. Genetics of convulsive disorders. II. Genetic and electroencephalographic studies in centrencephalic epilepsy. Neurology 11, 474-483 (1961).
2. Robinson R, Taske N, Sander T et al. Linkage analysis between childhood absence epilepsy and genes encoding GABAA and GABAB receptors, voltage-dependent calcium channels,and the ECA1 region on chromosome 8q. Epilepsy Res. 48, 169-179 (2002).
3. Fong GC, Shah PU, Gee MN et al. Childhood absence epilepsy with tonic-clonic seizures and electroencephalogram 3-4-Hz spike and multispike-slow wave complexes: linkage to chromosome 8q24. Am. J. Hum. Genet. 63, 1117-1129 (1998).
4. 2-subunit in childhood absence epilepsy and febrile seizures. Nat. Genet. 28, 49-52 (2001).
5. Chen Y, Lu J, Pan H et al. Association between genetic variation of CACNA1H and childhood absence epilepsy. Ann. Neurol. 54, 239-243 (2003).
6. Cossette P, Liu L, Brisebois K et al. Mutation of GABRA1 in an autosomal dominant form of juvenile myoclonic epilepsy. Nat. Genet. 31, 184-189 (2002).
7. Krampfl K, Maljevic S, Cossette P et al. Molecular analysis of the A322D mutation in the GABA receptor α-subunit causing juvenile myoclonic epilepsy. Eur. J. Neurosci. 22, 10-20 (2005).
8. Haug K, Warnstedt M, Alekov AK et al. Mutations in CLCN2 encoding a voltage-gated chloride channel are associated with idiopathic generalized epilepsies. Nat. Genet. 33, 527-532 (2003).
9. Suzuki T, Delgado-Escueta AV, Aguan K et al. Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat. Genet. 36, 842-849 (2004).
10. Scheffer IE, Berkovic SF. Generalized epilepsy with febrile seizures plus. A genetic disorder with heterogeneous clinical phenotypes. Brain 120(Pt 3), 479-490 (1997).
11. Singh R, Scheffer IE, Crossland K, Berkovic SF. Generalized epilepsy with febrile seizures plus: a common childhood-onset genetic epilepsy syndrome. Ann. Neurol. 45, 75-81 (1999).
12. Baulac S, Gourfinkel-An I, Picard F et al. A second locus for familial generalized epilepsy with febrile seizures plus maps to chromosome 2q21-q33. Am. J. Hum. Genet. 65, 1078-1085 (1999).
13. +). Epilepsia 46(Suppl. 10), 41-47 (2005).
14. 1 subunit gene SCN1B. Nat. Genet. 19, 366-370 (1998).
15. +) on chromosome 2q24-q33. Am. J. Hum. Genet. 65, 1396-1400 (1999).
16. 1-subunit mutations in generalized epilepsy with febrile seizures plus. Am. J. Hum. Genet. 68, 859-865 (2001).
17. 2-subunit gene. Nat. Genet. 28, 46-48 (2001).
18. + phenotypes associated with SCN1B mutations. Brain 130, 100-109 (2007).
19. Audenaert D, Claes L, Ceulemans B, Lofgren A, Van Broeckhoven C, De Jonghe P. A deletion in SCN1B is associated with febrile seizures and early-onset absence epilepsy. Neurology 61, 854-856 (2003).
20. Abou-Khalil B, Ge Q, Desai R et al. Partial and generalized epilepsy with febrile seizures plus and a novel SCN1A mutation. Neurology 57, 2265-2272 (2001).
21. 1 subunit mutation responsible for generalized epilepsy with febrile seizures plus type 1. J. Neurosci. 22, 10699-10709 (2002).
22. Spampanato J, Escayg A, Meisler MH, Goldin AL. Functional effects of two voltage-gated sodium channel mutations that cause generalized epilepsy with febrile seizures plus type 2. J. Neurosci. 21, 7481-7490 (2001).
23. Lossin C, Rhodes TH, Desai RR et al. Epilepsy-associated dysfunction in the voltage-gated neuronal sodium channel SCN1A. J. Neurosci. 23, 11289-11295 (2003).
24. Lossin C, Wang DW, Rhodes TH, Vanoye CG, George AL Jr. Molecular basis of an inherited epilepsy. Neuron 34, 877-884 (2002).
25. v1.1 sodium channels. Neuroscience 116, 37-48 (2003).
26. Spampanato J, Kearney JA, de Haan G et al. A novel epilepsy mutation in the sodium channel SCN1A identifies a cytoplasmic domain for β subunit interaction. J. Neurosci. 24, 10022-10034 (2004).
27. Dravet C. Les epilepsies graves de l'enfant. Vie Médicale 8, 543-548 (1978).
28. Jansen FE, Sadleir LG, Harkin LA et al. Severe myoclonic epilepsy of infancy (Dravet syndrome): recognition and diagnosis in adults. Neurology 67, 2224-2226 (2006).
29. Ohmori I, Ohtsuka Y, Ouchida M et al. Is phenotype difference in severe myoclonic epilepsy in infancy related to SCN1A mutations? Brain Dev. 25, 488-493 (2003).
30. Ohmori I, Ouchida M, Ohtsuka Y, Oka E, Shimizu K. Significant correlation of the SCN1A mutations and severe myoclonic epilepsy in infancy. Biochem. Biophys. Res. Commun. 295, 17-23 (2002).
31. Sugawara T, Mazaki-Miyazaki E, Fukushima K et al. Frequent mutations of SCN1A in severe myoclonic epilepsy in infancy. Neurology 58, 1122-1124 (2002).
32. Fujiwara T, Sugawara T, Mazaki-Miyazaki E et al. Mutations of sodium channel α subunit type 1 (SCN1A) in intractable childhood epilepsies with frequent generalized tonic-clonic seizures. Brain 126, 531-546 (2003).
33. 1 subunit gene SCN1A in core severe myoclonic epilepsy in infancy (SMEI) and in borderline SMEI (SMEB). Epilepsia 45, 140-148 (2004).
34. Harkin LA, McMahon JM, Iona X et al. The spectrum of SCN1A-related infantile epileptic encephalopathies. Brain 130, 843-852 (2007).
35. Claes L, Del-Favero J, Ceulemans B, Lagae L, Van Broeckhoven C, De Jonghe P. De novo mutations in the sodium-channel gene SCN1A cause severe myoclonic epilepsy of infancy. Am. J. Hum. Genet. 68, 1327-1332 (2001).
36. Mulley JC, Scheffer IE, Petrou S, Dibbens LM, Berkovic SF, Harkin LA. SCN1A mutations and epilepsy. Hum. Mutat. 25, 535-542 (2005).
37. Depienne C, Arzimanoglou A, Trouillard O et al. Parental mosaicism can cause recurrent transmission of SCN1A mutations associated with severe myoclonic epilepsy of infancy. Hum. Mutat. 27, 389 (2006).
38. Gennaro E, Santorelli FM, Bertini et al. Somatic and germline mosaicisms in severe myoclonic epilepsy of infancy. Biochem. Biophys. Res. Commun. 341, 489-493 (2006).
39. Marini C, Mei D, Helen Cross J, Guerrini R. Mosaic SCN1A mutation in familial severe myoclonic epilepsy of infancy. Epilepsia 47, 1737-1740 (2006).
40. Morimoto M, Mazaki E, Nishimura A et al. SCN1A mutation mosaicism in a family with severe myoclonic epilepsy in infancy. Epilepsia 47, 1732-1736 (2006).
41. 2 subunit in a family with generalized epilepsy with febrile seizures plus. Am. J. Hum. Genet. 70, 530-536 (2002).
42. Scheffer IE, Bhatia KP, Lopes-Cendes I et al. Autosomal dominant nocturnal frontal lobe epilepsy. A distinctive clinical disorder. Brain 118(Pt 1), 61-73 (1995).
43. Phillips HA, Marini C, Scheffer IE, Sutherland GR, Mulley JC, Berkovic SF. A de novo mutation in sporadic nocturnal frontal lobe epilepsy. Ann. Neurol. 48, 264-267 (2000).
44. Phillips HA, Scheffer IE, Berkovic SF, Hollway GE, Sutherland GR, Mulley JC. Localization of a gene for autosomal dominant nocturnal frontal lobe epilepsy to chromosome 20q 13.2. Nat. Genet. 10, 117-118 (1995).
45. 4 subunit is associated with autosomal dominant nocturnal frontal lobe epilepsy. Nat. Genet. 11, 201-203 (1995).
46. 2 subunit is mutant in nocturnal frontal lobe epilepsy. Nat. Genet. 26, 275-276 (2000).
47. Phillips HA, Favre I, Kirkpatrick M et al. CHRNB2 is the second acetylcholine receptor subunit associated with autosomal dominant nocturnal frontal lobe epilepsy. Am. J. Hum. Genet. 68, 225-231 (2001).
48. Phillips HA, Scheffer IE, Crossland KM et al. Autosomal dominant nocturnal frontal-lobe epilepsy: genetic heterogeneity and evidence for a second locus at 15q24. Am. J. Hum. Genet. 63, 1108-1116 (1998).
49. Bonati MT, Combi R, Asselta R et al. Exclusion of linkage of nine neuronal nicotinic acetylcholine receptor subunit genes expressed in brain in autosomal dominant nocturnal frontal lobe epilepsy in four unrelated families. J. Neurol. 249, 967-974 (2002).
50. Bertrand S, Weiland S, Berkovic SF, Steinlein OK, Bertrand D. Properties of neuronal nicotinic acetylcholine receptor mutants from humans suffering from autosomal dominant nocturnal frontal lobe epilepsy. Br. J. Pharmacol. 125, 751-760 (1998).
51. 2 acetylcholine response. J. Physiol. 550, 11-26 (2003).
52. Poza JJ, Saenz A, Martinez-Gil A et al. Autosomal dominant lateral temporal epilepsy: clinical and genetic study of a large Basque pedigree linked to chromosome 10q. Ann. Neurol. 45, 182-188 (1999).
53. Winawer MR, Ottman R, Hauser WA, Pedley TA. Autosomal dominant partial epilepsy with auditory features: defining the phenotype. Neurology 54, 2173-2176 (2000).
54. Kobayashi E, Santos NF, Torres FR et al. Magnetic resonance imaging abnormalities in familial temporal lobe epilepsy with auditory auras. Arch. Neurol. 60, 1546-1551 (2003).
55. Ottman R, Risch N, Hauser WA et al. Localization of a gene for partial epilepsy to chromosome 10q. Nat. Genet. 10, 56-60 (1995).
56. Kalachikov S, Evgrafov O, Ross B et al. Mutations in LGI1 cause autosomaldominant partial epilepsy with auditory features. Nat. Genet. 30, 335-341 (2002).
57. Morante-Redolat JM, Gorostidi-Pagola A, Piquer-Sirerol S et al. Mutations in the LGI1/epitempin gene on 10q24 cause autosomal dominant lateral temporal epilepsy. Hum. Mol. Genet. 11, 1119-1128 (2002)
58. Michelucci R, Poza JJ, Sofia V et al. Autosomal dominant lateral temporal epilepsy: clinical spectrum, new epitempin mutations, and genetic heterogeneity in seven European families. Epilepsia 44, 1289-1297 (2003).
59. Ottman R, Winawer MR, Kalachikov S et al. LGI1 mutations in autosomal dominant partial epilepsy with auditory features. Neurology 62, 1120-1126 (2004).
60. Bisulli F, Tinuper P, Avoni P et al. Idiopathic partial epilepsy with auditory features (IPEAF): a clinical and genetic study of 53 sporadic cases. Brain 127, 1343-1352 (2004).
61. Bisulli F, Tinuper P, Scudellaro E et al. A de novo LGI1 mutation in sporadic partial epilepsy with auditory features. Ann. Neurol. 56, 455-456 (2004).
62. Senechal KR, Thaller C, Noebels JL. ADPEAF mutations reduce levels of secreted LGI1, a putative tumor suppressor protein linked to epilepsy. Hum. Mol. Genet. 14, 1613-1620 (2005).
63. Fukata Y, Adesnik H, Iwanaga T, Bredt DS, Nicoll RA, Fukata M. Epilepsy-related ligand/receptor complex LGI1 and ADAM22 regulate synaptic transmission. Science 313, 1792-1795 (2006).
64. Sirerol-Piquer MS, Ayerdi-Izquierdo A, Morante-Redolat JM et al. The epilepsy gene LGI1 encodes a secreted glycoprotein that binds to the cell surface. Hum. Mol. Genet. 15, 3436-3445 (2006).
65. Schulte U, Thumfart JO, Klocker N et al. The epilepsy-linked Lgi1 protein assembles into presynaptic Kv1 channels and inhibits inactivation by Kvβ1. Neuron 49, 697-706 (2006).
66. Furlan S, Roncaroli F, Forner F et al. The LGI1/epitempin gene encodes two protein isoforms differentially expressed in human brain. J. Neurochem. 98, 985-991 (2006).
67. Xiong L, Labuda M, Li DS et al. Mapping of a gene determining familial partial epilepsy with variable foci to chromosome 22q11-q12. Am. J. Hum. Genet. 65, 1698-1710 (1999).
68. Berkovic SF, Serratosa JM, Phillips HA et al. Familial partial epilepsy with variable foci: clinical features and linkage to chromosome 22q12. Epilepsia 45, 1054-1060 (2004).
69. Scheffer IE, Phillips HA, O'Brien CE et al. Familial partial epilepsy with variable foci: a new partial epilepsy syndrome with suggestion of linkage to chromosome 2. Ann. Neurol. 44, 890-899 (1998).
70. Callenbach PM, van den Maagdenberg AM, Hottenga JJ et al. Familial partial epilepsy with variable foci in a Dutch family: clinical characteristics and confirmation of linkage to chromosome 22q. Epilepsia 44, 1298-1305 (2003).
71. Rett A, Teubel R. Neugeborenenkrampfe im Rhamen einer epileptisch belasten Familie. Wien. Klein. Wochenschr. 76, 609-612 (1964).
72. de Haan GJ, Pinto D, Carton D et al. A novel splicing mutation in KCNQ2 in a multigenerational family with BFNC followed for 25 years. Epilepsia 47, 851-859 (2006).
73. Ronen GM, Rosales TO, Connolly M, Anderson VE, Leppert M. Seizure characteristics in chromosome 20 benign familial neonatal convulsions. Neurology 43, 1355-1360 (1993).
74. Biervert C, Schroeder BC, Kubisch C et al. A potassium channel mutation in neonatal human epilepsy. Science 279, 403-406 (1998).
75. Charlier C, Singh NA, Ryan SG et al. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18, 53-55 (1998).
76. Singh NA, Charlier C, Stauffer D et al. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18, 25-29 (1998).
77. Claes LR, Ceulemans B, Audenaert D et al. De novo KCNQ2 mutations in patients with benign neonatal seizures. Neurology 63, 2155-2158 (2004).
78. + channels and the molecular pathogenesis of epilepsy: implications for therapy. Trends Neurosci. 23, 393-398 (2000).
79. Tinel N, Lauritzen I, Chouabe C, Lazdunski M, Borsotto M. The KCNQ2 potassium channel: splice variants, functional and developmental expression. Brain localization and comparison with KCNQ3. FEBS Lett. 438, 171-176 (1998).
80. Kaplan RE, Lacey DJ. Benign familial neonatal-infantile seizures. Am. J. Med. Genet. 16, 595-599 (1983).
81. Berkovic SF, Heron SE, Giordano L et al. Benign familial neonatal-infantile seizures: characterization of a new sodium channelopathy. Ann. Neurol. 55, 550-557 (2004).
82. + channel causing benign familial neonatal-infantile seizures. J. Neurosci. 26, 10100-10109 (2006).
83. Ottman R. Analysis of genetically complex epilepsies. Epilepsia 46(Suppl. 10), 7-14 (2005).
84. Mulley JC, Scheffer IE, Petrou S, Berkovic SF. Channelopathies as a genetic cause of epilepsy. Curr. Opin. Neurol. 16, 171-176 (2003).
85. Carlson CS, Eberle MA, Kruglyak L, Nickerson DA. Mapping complex disease loci in whole-genome association studies. Nature 429, 446-452 (2004).
86. Hirschhorn JN, Daly MJ. Genome-wide association studies for common diseases and complex traits. Nat. Rev. Genet. 6, 95-108 (2005).
87. Berkovic SF, Howell RA, Hay DA, Hopper JL. Epilepsies in twins: genetics of the major epilepsy syndromes. Ann. Neurol. 43, 435-445 (1998).
88. Ottman R, Lee JH, Risch N, Hauser WA, Susser M. Clinical indicators of genetic susceptibility to epilepsy. Epilepsia 37, 353-361 (1996).